Brief: Anika Therapeutics Q2 Revenue USD 41.921 Million
08/08/2024 21:06
Aug 08 (Reuters) - Anika Therapeutics Q2 gross profit USD 27.365 million. * Q2 income from operations USD 161 thousand * Q2 pretax profit USD 756 thousand * Q2 net income USD -88 thousand
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%